Leading proxy advisory firm glass lewis recommends mindmed shareholders vote for all six company nominees

New york--(business wire)---- $mnmd--mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (the “company” or “mindmed”) today announced that leading proxy advisory firm glass, lewis & co. (“glass lewis”) recommends shareholders vote for the election of all of mindmed's six highly qualified director nominees to the board of directors (the “board”) at the upcoming annual meeting of shareholders (“annual meeting”), scheduled for june 15, 2023. previously, leading proxy advisory firm institutional sh.
MNMD Ratings Summary
MNMD Quant Ranking